Cytomegalovirus reactivation in an extensively pretreated multiple myeloma patient during daratumumab treatment

We report a case of symptomatic cytomegalovirus (CMV) reactivation upon initiation of daratumumab monotherapy treatment in a heavily pre-treated multiple myeloma (MM) patient.

Source: Clinical Lymphoma, Myeloma and Leukemia - October 12, 2018 Category: Hematology Authors: Kristine A. Frerichs, Patricia W.C. Bosman, Inger S. Nijhof, S. Zweegman, Niels W.C.J. van de Donk Tags: Case Report Source Type: research